Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Cemil Boyoglu"'
Autor:
Sucheta D’Sa, Kimberly Braz Gomes, Grace Lovia Allotey-Babington, Cemil Boyoglu, Sang-Moo Kang, Martin J. D’Souza
Publikováno v:
Vaccines, Vol 10, Iss 4, p 584 (2022)
No approved vaccines against respiratory syncytial virus (RSV) infections exist to date, due to challenges arising during vaccine development. There is an unmet need to explore novel approaches and a universal strategy to prevent RSV infections. Prev
Externí odkaz:
https://doaj.org/article/639df48246554e27a333cf1c5fe9141c
Autor:
Lia M. Haynes, Martin L. Moore, Larry J. Anderson, Thomas R. Barnum, Patricia A. Jorquera, Sean O. Todd, Cemil Boyoglu, Ralph A. Tripp, Kelsey A. Gaston, Seyhan Boyoglu-Barnum, Tatiana Chirkova
Publikováno v:
Journal of Virology. 87:10955-10967
Respiratory syncytial virus (RSV) belongs to the family Paramyxoviridae and is the single most important cause of serious lower respiratory tract infections in young children, yet no highly effective treatment or vaccine is available. Increased airwa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9eec37b94e6c1784ee1cdc9882c67d9
https://doi.org/10.1128/jvi.01164-13
https://doi.org/10.1128/jvi.01164-13
Autor:
Shreekumar Pillai, Shree R. Singh, Vida A. Dennis, Qingwen He, Gerold A. Willing, Cemil Boyoglu, Seyhan Boyoglu-Barnum
Publikováno v:
ISRN Nanotechnology. 2013:1-13
Gold nanoparticles (GNPs) are widely used in biological and clinical applications due to their favorable chemical and optical properties. GNPs can be used for drug delivery to targeted cells. In addition, GNPs serve as ideal probes for biological and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8effdedb7d32ba7d81b3e10539a82c4
https://doi.org/10.1155/2013/123838
https://doi.org/10.1155/2013/123838